Healthcare and life sciences in Israel

Goldfarb Seligman & Co.

Goldfarb Seligman & Co.'s comprehensive practice is equally skilled in regulatory and transactional work involving major life sciences clients, including pharmaceutical companies, medical device companies, hospitals and doctors. The firm's dominant position in the market is illustrated by its central role in landmark cases. In a recent highlight, the firm advised Baring Private Equity Asia PTE on its $1.2bn acquisition of Lumenis. Sharon Gazit, who serves as co-chair of the healthcare and life sciences law committee of the IBA, has a strong reputation in the biomedical and life sciences fields. Judy Amidor is also a very active member of the firm's life sciences team.

Practice head(s):

Sharon Gazit; Ashok Chandrasekhar; Aaron Michaeli

Other key lawyers:

Judy Amidor


‘Very strong support from this firm on an international basis – business minded and understand how the technology is driving the economy.’’

‘Sharon Gazit is a truly reliable and pleasant person to work with. She has a corporate profile but is able to cover a larger range of matters including regulatory issues and innovation in the life sciences sector.’ 

Key clients

Baring Private Equity Asia PTE. Ltd.

BrainsGate Ltd.

EarlySense Ltd.

Novo Nordisk A/S

ReWalk Robotics Ltd.

Lilach – Live and Die with Dignity

The Israeli Medical Association

Magen David Adom In Israel

Maccabi Healthcare Services

Carestream Health, Inc.

Aquafit Intimate Ltd.

National Insurance Institute of Israel

Anchiano Therapeutics

Itamar Medical Ltd.

Bar-Ilan Research & Development Company Ltd.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Wize Pharma Ltd.

Breath of Life International Ltd. (BOL Group).

Cannbit Ltd.


Work highlights

  • Advised Baring Private Equity Asia PTE. Ltd. on its $1.2bn acquisition of Lumenis Ltd. from Chinese private equity fund XIO Group.
  • Advising EarlySense on a variety of agreements with leading hospitals, medical centres, multinational corporations and other entities across the globe, including clinical trials, joint development, technology license, technology transfer and cloud development investments.
  • Advising Magen David Adom In Israel (MDA) on unique healthcare projects and initiatives, such as the establishment of a new blood bank, a national breast milk bank, a cross-border clinical trial agreement and more.

Herzog Fox & Neeman

While Herzog Fox & Neeman's team has expertise across the healthcare and life sciences sectors but is especially known for its specialism in IP, including patent litigation, licensing and distribution. In addition, it is a strong practice for clients in the burgeoning medical cannabis sector looking to manage the Israeli regulatory regime and consolidate their operations in Israel. Zohar Yahalom has established himself as an expert in the regulation of Israel's healthcare system and pharmaceutical sector, having served in various national committees responsible for legislation in these areas. Neta Dorfman-Raviv is a standout name for work in the health insurance field.

Practice head(s):

Zohar Yahalom; Neta Dorfman-Raviv

Other key lawyers:

Dan Sharot


‘The HFN healthcare and life science practice is a business-minded, capable and creative team that is practical, efficient and knowledgeable. They know the global industry’s ins and outs and possess an in-depth understanding of the Israeli aspects in a way that is truly exceptional.’ 

‘Their efficient, experienced, responsive and professional team makes working with them a pleasure.’

Key clients

Assuta Ashdod

Assuta Medical Centers

Maccabi Health Services

Magen David Adom



Merck Serono

Eli Lilly Israel

GE HealthCare


Novo Nordisk

Philips Healthcare

Isotopia Molecular Imaging

Super Pharm

Boehringer Ingelheim Israel

Work highlights

  • Advising the Novolog group on all aspects of its activity, including, in the past year, on all regulatory and privacy aspects of its operations, and on all types of commercial and quality agreements between the group and other entities.
  • Advising Merck Serono local affiliate on all aspects of its activity, including commercial, regulatory, privacy and labour advice.
  • Advising General Magen David Adom, on its regulatory, corporate and administrative law matters, in addition to certain commercial and employment matters.

Horn & Co

Boutique firm Horn & Co specialises in advising life sciences and biotech clients on all aspects of their operations, including corporate transactions and commercial agreements. The team's track record in IP matters is particularly strong, illustrated by the high volume of licensing deals that it handles. Yuval Horn serves as lead counsel to numerous clients in the life sciences sector on significant transactions, including M&A and IPOs. In recent work, she advised Pontifax on its formation of a venture lending fund, involving negotiations with multiple investors. Keren Kanir specialises in corporate finance and commercial transactions involving IP issues.

Practice head(s):

Yuval Horn

Other key lawyers:

Keren Kanir

Key clients

Pontifax VC

Protalix Biotherapeutics Inc.

Vascular Biogenics Ltd.

Biolight Life Sciences Ltd.

Aposense Ltd.

Zebra Medical Vision

Biosight Ltd.

Lutris Pharma Ltd.

Work highlights

  • Advised Pontifax’s venture lending fund on a $30m convertible debt financing agreement with ProQR Therapeutics N.V., a Dutch company traded on Nasdaq, developing transformative RNA therapies for the treatment of rare genetic diseases.
  • Advising Neovii Biopharmaceuticals GmbH on an exclusive license agreement with Tel Aviv University for the license of an innovative platform developed by Prof. Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology at TAU’s George S. Wise Faculty of Life Sciences, including his innovative vaccine design for the corona family of viruses.
  • Advising Lutris Pharma Ltd., an Israeli startup developing novel dermatologic therapeutics, on an exclusive license agreement with Memorial Sloan Kettering for the licensing of innovative technology in the field of BRAF inhibitors for treating cutaneous reactions.

Lipa Meir & Co

Lipa Meir & Co excels in the medical cannabis sector, having advised various start-ups and established companies on their corporate and commercial agreements in Israel. Additionally, the team is often instructed by well-known healthcare and pharmaceutical companies to assist with M&A, investments and licensing agreements. The firm has recently handled a high volume of work in the areas of privacy and medical research as a result of issues related to Covid-19. Gary Copelovitz stands out for his ongoing work for Clalit Health Services, Israel's largest HMO.

Practice head(s):

Gary Copelovitz

Other key lawyers:

Mier Elbaum; Roy Aiz

Key clients

Clalit Health Services

Lahav CRO

Monday Swiss AG

Mor Institute for Medical Data Ltd.

Mor-Mar Ltd.

Tel Hashomer

Shila Medical Services Ltd.

Mor Research Applications Ltd.

NARA Medical Center

Medtechnica Orthophone Ltd.

Nevo Medical Ltd.

Natural Birthing Center

Clal Insurance Company Ltd.

Tel Bar Industries For Health Institutions Ltd.

Nevo Robotica

Clalit Biomedical Engineering Ltd.

Eroll Grow-Tech Ltd.



Kibbutz Alumim

Menora Mivtachim Holdings Ltd.

Foamix Pharmaceuticals Ltd.

Blistex Inc.

Brosh Pharm Ltd.


Work highlights

  • Advising Clalit on various matters, including all of its tenders regarding medical devices, equipment and drugs, and in relation to its joint venture with a Swiss-US conglomerate to establish a bio bank.
  • Advised Tel Hashomer on an agreement with the state to evacuate land to market residential land and establish an advanced medical centre.
  • Advising Mileutis, a clinical-stage biopharmaceutical company focused on developing and commercializing natural and novel peptides for animal and human health, in relation to agreements with several confidential clients.

M. Firon & Co Advocates and Notaries

M. Firon & Co Advocates and Notaries' team advises a broad range of international and domestic clients on business ventures across the US, Europe, Asia and Israel, including M&A transactions and licensing agreements. Baruch Shogul has considerable experience advising clients in the pharmaceutical industry on business critical matters, including major mergers. Sivan Narkiss has cultivated a strong working knowledge of the regulation governing healthcare and pharmaceutical companies.

Practice head(s):

Baruch Shugol; Sivan Narkiss


‘Baruch Shogul – an absolute authority on healthcare law and regulation.’

‘Sivan Narkiss – an excellent young partner with a deep understanding of healthcare.’

‘The Firon team possesses rare expertise in the relevant legal disciplines relating to software and hi-tech in general, and with regard to large M&A transactions. Additionally, they are experts in the healthcare sector. Our only choice.’

Key clients



Tel Aviv Sourasky Medical Centre

Clalit Health Services

Pharma Israel


EMMS Nazareth Hospital

Hadassah Medical

Herzliya Medical Centre

S.L.H. Medical Services Ltd.

Guangzhou Sino-Israel Bio-industry Venture Capital Investment Fund

CorNeat Vision


Geffen Medical

Work highlights

  • Advising EMMS Nazareth Hospital regarding its new IVF department and emergency room.
  • Advising Pharma Israel (the association representing the R&D-based multinational pharmaceutical companies operating in Israel) on all aspects of the whole industry’s dialogue and relationship with regulators and the Ministry of Health.
  • Advising Sanofi on all of its legal matters in Israel, including clinical trial and privacy and competition issues.

S. Horowitz & Co

S. Horowitz & Co has a strong track record in transactional and contentious mandates involving prominent clients across the spectrum of healthcare and life sciences. In the field of litigation, the team has an excellent reputation in complex disputes, including major class actions. Recently, it was chosen to represent Taro Pharmaceuticals in the first class action filed in Israel regarding the affect of opioids. Tal Band is best known for representing life sciences clients in administrative litigation. Dovev Apel is often engaged in major legislative developments led by the Ministry of Health and the Knesset, in addition to regularly representing clients in IP litigation, product liability disputes and class actions.

Practice head(s):

Tal Band; Dovev Apel

Other key lawyers:

Asaf Rentsler; Moran Katz; Yair Ziv

Key clients

Teva Pharmaceutical Industries Ltd.

The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel

Maccabi Healthcare Services

Procter & Gamble Israel Ltd

Dexcel Ltd. and Dexcel Pharma Technologies Ltd.

Novocure Inc.

Hadassah Medical Organization

Allergan Inc.

SelfCare Pro

Indena S.p.A.

Forever Living Products (Israel) Limited

Taro Pharmaceutical Industries Ltd.

Genmab A/S

Medial Group

Santhera Pharmaceuticals

Yeda Research and Development Limited


I.S.R – The Institute for Skin Research

Zimmer Biomet

Takeda Pharmaceutical Company

Sanofi Aventis

Galmed International Ltd.

Hadasit Medical Research Services and Development Ltd.

Advanced Oncotherapy plc.

Solomon, Levine, and Elstein Ltd.

8679410 CANADA INC.

Simplivia Healthcare ltd.

Tel Aviv University

M.I.P Veterinary ltd.

Euromar Ltd.

Amgen Inc.

Work highlights

  • Representing Teva in a precedential lawsuit against Abbot Israel, a domestic importer of the global baby formula brand “Similac.” The multifaceted dispute includes the alleged use of fictitious profiles and paid commenters on social media to promote the Similac brand and negatively influence sales of Teva’s Nutrilon brand.
  • Representing Sanofi Aventis in a highly complex motion to certify a NIS1.5bn class action concerning the alleged lack of information on its patient information leaflet of Sanofi’s product regarding a possible risk of insomnia.
  • Representing Taro Pharmaceutical Industries Ltd. in a motion seeking to certify a class action that focuses on allegations of insufficient and misleading information in the consumer medicine leaflet with respect to the potential risks of the opioid, analgesics.

Tadmor Levy & Co

Tadmor Levy & Co.'s 'smart and knowledgeable team' acts for a diverse roster of clients, including major hospitals, healthcare providers, start-ups and multinational pharmaceutical companies. The group assists with regulatory compliance, commercial agreements and corporate transactions. The team is also well known for its expertise in clinical research, which includes acting as internal counsel for institutional review boards. Efrat Shapira Orren provides full service advice, including representing clients before the Ministry of Health in relation to various matters. Associate Avital Bruker-Yamin provides additional support.

Practice head(s):

Efrat Shapira-Orren

Other key lawyers:

Avital Bruker-Yamin


‘Very dedicated team. Respond very quickly and give clear answers.’ 

Key clients

Assuta Medical Centers Ltd.

Assuta Ashdod Ltd.

Incentive Incubator Ltd.

SAREL Supplies & Services for Medicine Ltd.

Corsens Medical Ltd

Sinusafe Medical Ltd.

ArTack Medical (2013) Ltd.

Allergan Plc

Baxter Healthcare Distribution Ltd.

Stryker Corporation

Super Spectra

Alpha Bio Tec. Ltd.

Endomatoc Ltd.

Work highlights

  • Advising Assuta in relation to activity ranging from regulation and governance, to commercial agreements, corporate structuring, as well as antitrust, real estate, employment and issues surrounding privacy, security and database registry.
  • Representing Allergan Plc in a motion to certify a $40.5bn derivative action against the board members of Teva Pharmaceutical Industries Ltd and Allergan.
  • Advising Incentive Incubator Ltd. in connection with all of its investment activity.

Yigal Arnon & Co

Yigal Arnon & Co's 'highly dedicated' team has notable expertise in the areas of technology and IP, which is particularly valuable to its life sciences clients. It is also very experienced in corporate transactions, compliance strategies and product liability matters. Yoheved Novogroder-Shoshan focuses predominantly on licensing, technology transfers, development, supply and distribution agreements, acting for clients across the life sciences industry. Barry Levenfeld focuses on all forms of transactions involving technology and life sciences clients; he is also an expert in IP law. Associate Miriam Friedmann also has notable expertise in IP law.

Practice head(s):

Daniel Green; Yohoeved Novogroder-Shoshan; Barry Levenfeld

Other key lawyers:

Miriam Friedmann; Joeri Kreisberg; Eli Greenbaum


‘Great professional team. Highly dedicated and committed. ’

‘YA provide critical guidance – alerting me to issues that require deeper understanding.’ 

‘YA is responsive and responsible. They will go the extra mile when necessary.’

‘The team that works with me is responsive, insightful, personable, and smart. They are creative when problem-solving. They are rigid and strict where necessary. I always get a straight answer, even if it’s the answer I was hoping not to hear. But they are quick to offer the best solutions available.’

Key clients

Bioventus LLC

Human Xtensions

Barclays Capital

Pocared Diagnostics Ltd.

Teva Pharmaceutical Industries Ltd.

Oculis SA


MEDX XELERATOR, Limited partnership

ALYN Hospital

Atox Bio

Enlivex Therapeutics Ltd.

Sirvir Ltd.

Prilenia Therapeutics

Hubei Forbon Technology Co., Ltd.

Alma Lasers Ltd.

Integra Holdings

Simplificare, Inc.

Premia Spine

RMDY Health

On-Sight Medical

Genmab A/S


Work highlights

  • Advising FutuRx and its portfolio companies on life sciences-related IP licensing transactions.
  • Advising Bioventus on its investment in Israeli medical device company Cartiheal, including signing an option to buy it.
  • Advised Barclays Capital as lead underwriter of the IPO of clinical-stage bio-pharmaceutical company PolyPid Therapeutics on NASDAQ, raising $60m.

Amit, Pollak, Matalon & Co. Advocates and Notary

Amit, Pollak, Matalon & Co. Advocates and Notary distinguishes itself from peers through its strong investor side practice, and its excellent reputation for advising start-ups in various sectors, including medical cannabis and biotech. In addition, the team is well known for advising clients on financing rounds, joint ventures and private equity transactions. Ian Rostowsky specialises in M&A and venture capital transactions, and fellow practice head Yoav Etzyon is often instructed to advise on debt and equity offerings in Israel and the US.

Practice head(s):

Ian Rostowsky; Yoav Etzyon

Key clients

Nanox Imaging Ltd.

Motus GI

Orpheus Medical

KeepMed Ltd.

aMoon Fund

aMoon Velocity Fund

MindUP Ltd.

Novartis International AG

Health& Happiness Group

Panaxia Pharmaceutical Industries Ltd.

Epitech Mag Ltd.

Xinteza API Ltd.

Human Mission Inc.

DermaFence Ltd.


Chemo Group/Exeltis

Orsense Ltd.


APX Ophthalmology Ltd.

TearFlow Care Ltd.

Healeon Medical Ltd.

Work highlights

  • Advised Nano-X Imagining on its $110m capital raising between December 2019 and July 2020.
  • Assisted aMoon II with its formation and $750m fundraising.
  • Advising Panaxia on several high volume commercial transactions promoting its global reach and expansion.


FISCHER (FBC & Co.)'s team has a comprehensive offering in the area of healthcare and life sciences, which includes assisting with IP licensing, privacy and data protection, M&A, trade mark and patent disputes and competition law. Among recent work highlights, the firm represented several medical device companies (including Alpha-Bio Tech and Medici Medical) in complex class product liability claims. Raz Tepper is very active in various fields, including biopharmaceuticals, biotechnology and genomics. Eran Yaniv focuses on cross-border transactions in the life sciences and technology sectors.

Practice head(s):

Raz Tepper; Eran Yaniv

Other key lawyers:

Shmulik Fried; Warren Wienburg


‘The team is highly professional, covering many legal and business aspects of my company. At the same time, they are very friendly and approachable.’

‘I recently founded a second company, and I called upon the same team to assist with the establishment and all the legal requirements of the company. This is a testament to my trust and satisfaction with the legal team. I think the best description of my relationship with the legal team is trust. I trust their professional judgement and I trust them to convey the legal information and requirements to me in the best possible way. ’

Key clients

AngioDynamics Inc.

Hadaseed LP

Abbott – St. Jude Medical

Adicet Bio Ltd.

Allium Medical

Alpha-Bio Tech Ltd.

American Well Corporation

Bristol-Meyers Squibb Company

Hadassah Medical Organisation

Meuhedet Health Fund

Check Cap Ltd.

Kamada Ltd.

Lifebond Ltd.

Medica Medical Centres

MetaboMed Ltd.

M.S.T. Medical Surgery Technologies Ltd.

Motus G.I.

NanoSpun Technologies

Nano Retina Ltd.


OrbiMed Healthcare Fund

Pangea Therapeutics Ltd.

Perrigo Company

Pythagoras Medical Ltd.

Rainbow Medical Ltd.

Real Imaging Holdings Ltd.

Work highlights

  • Advising Hadassah Hospital – the largest non-governmental hospital in Israel – on an ongoing basis, including with respect to regulatory and other matters.
  • Advising AngioDynamics on its acquisition of Eximo Medical Ltd.
  • Advising Check-Cap on an ongoing basis, including in relation to corporate, commercial, employment, data privacy, regulatory compliance, as well as financing and capital markets matters.

Gross Law Firm – GKH

Gross Law Firm – GKH is particularly well known for its expertise in the regulation governing ownership, licensing, clinical testing, use and transfer of biological samples. It is also sought after for its strong track record in marketing and M&A involving healthcare and life sciences companies. Hili Cohen guides clients through commercial transactions, including joint ventures, licensing and outsourcing arrangements.

Practice head(s):

Hili Cohen

Other key lawyers:

Tami Fishman Juktowitz

Key clients

3 Millenium Group



Align Technology, LTD

American Well

Arkin Holdings



Best Brain









ClearSkin Ltd.



Cronos Group

Edwards Lifesciences Corporation

Work highlights

  • Advised InnovaHealth Partners on an investment in Radiaction and a secondary transaction, totaling $18m.
  • Advised Sol-Gel Technologies in connection with its underwritten public offering of ordinary shares and warrants to purchase ordinary shares for aggregate gross proceeds of approximately $23m.
  • Advised Insightec on a Series F investment round of about $107m, principally from Koch Disruptive Technologies.

Liad Whatstein & Co. Law Office

Liad Whatstein & Co. Law Office specialises in IP law, which makes it a natural first choice for many healthcare and life sciences clients operating in Israel. The team is often involved in IP disputes and frequently guides clients through the regulatory regime applicable to their activities, including drug registration and pharmaceutical advertising. Recently, the firm acted for the state of Israel in major IP disputes involving life sciences and healthcare companies. 'Great trial lawyer' Liad Whatstein is highly regarded by clients involved in complex litigation involving life sciences issues and broader regulatory matters. Amira Mangelus is a key name for patent litigation.

Practice head(s):

Liad Whatstein; Amira Mangelus


‘Liad Whatstein is the best in Israel, and he has gathered brilliant people around him.’ 

‘Liad is a great trial lawyer: masters the facts, masters the law.’ 

‘Very high level of diligence and knowledge of the patent system in Israel. Easy to work with. Very aggressive at the appropriate time.’

‘I work with Liad Whatstein and Amira Mangelus. They are incredible attorneys, for the reason that I mentioned above, but also personally interesting, very easy and enjoyable to work with, and highly esteemed by my outside attorneys in other countries. ’

‘Liad and his team excel in translating the scientific and technological aspects of the matter into legal terms. They have broad-based understanding of science and technology subjects and their implications in a legal context.’

Key clients




The State of Israel


Eli Lilly

Leo Pharma

Pharma Israel





Dr. Fischer Pharmaceuticals

Novo Nordisk





Advanced Accelerators Applications


Work highlights

  • Acting for Sanofi in opposition and revocation proceedings in connection with Amgen’s patent for a new category of biological drugs for lowering cholesterol.
  • Acting for Novartis in several patent litigation proceedings, among others in connection with the successful Novartis drug AFINITOR (everolimus) for treating different tumour types, the well-known drug EXELON for treating Alzheimer’s disease and ENTRESTO for use in heart failure.
  • Representing Pfizer in an appeal in the Supreme Court in connection with Pfizer’s patent infringement proceedings against Unipharm in connection with the infringement of the patent for the well-known drug Viagra.

Meitar law offices

Meitar Law Offices' team recently recruited Alon Bachar, former head of the Privacy Protection Authority, who has notable expertise in all forms of data regulation. The team is known for providing a wide range of services to clients in this sector, spanning IP, product liability litigation and M&A, among other areas. Boaz Mizrahi advises on strategic agreements regarding licensing, manufacturing, distribution and sale of biotechnology and pharmaceutical products. Ron Peleg is a go-to name for clients involved in product liability suits and class actions.

Practice head(s):

Haim Gueta; Boaz Mizrahi; Ron Peleg

Other key lawyers:

Michal Weiner; Shay Reiner; Daniel Colthof; Alon Bachar


‘Highly professional team; response time is very quick and they are very transparent about the progress of matters.’ 

‘Boaz Mizrahi – Highly experienced and businesses oriented partner. Focused on problem solving.’

Key clients



Alpha Tau

Gamida Cell

Ayala Pharmaceuticals




Eli lilly






Bristol-Myers Squibb


Pharma Two Be

Stem Cells Medical

ChemomAB Ltd.

Tera Novel


Magentiq Eye

Medicane Research and Development


Ela Pharma

Actualize Health

Biokine Therapeutics



EZbra Advanced Wound Care


Work highlights

  • Advised Ayala Pharmaceuticals on the offering of its shares on Nasdaq, raising $55 million.
  • Represented Bayer Israel, Bayer Schering Pharma AG and Perrigo Israel Agencies Ltd. in a landmark judgment in the Supreme Court regarding pharmaceutical companies’ duty to disclose scientific information, holding that Bayer timely and adequately disclosed all relevant scientific information on possible side-effects to patients (appeal is pending).
  • Advised Mediwound  on the “sale” to Vericel Corporation of North American rights to NexoBrid®, a Biological Orphan Product for Debridement of Severe Thermal Burns.

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz is well known for handling contentious and non-contentious patent matters. The group also specialises in advising clients across the spectrum of life sciences on corporate transactions and employment issues. Zeev Pearl has over two decades of experience advising clients on IP issues, including portfolio development, licensing and litigation. Mark Cohen is an expert in patent prosecution regarding pharmaceuticals, medical devices and biotech. Yael Baratz is often instructed by clients to handle cross-border M&A transactions.

Practice head(s):

Zeev Pearl; Mark Cohen; Yael Baratz; Hili Rashkovan

Key clients

Bayer AG

Opko Health Ltd.

Pfizer Inc.

Sanofi S.A.

Orgenesis Inc.

Dexcel Pharma

Panaxia Pharmaceutical Industries Ltd

Maccabi Health Services

Biondvax Pharmaceuticals Ltd.

Ayala Pharmaceuticals

Verliy Life Sciences

SciVac Ltd.

KAHR Medical Ltd.

Ascend Performance Materials

Estar Medical

Amoon Fund

Nobio Ltd

Work highlights

  • Advised German multinational, Bayer AG, and its subsidiaries, on issues ranging from IP and regulatory to investments in Israel.
  • Advised Orgenesis and its subsidiaries on the full scope of M&A, commercial, corporate and IP matters, including the formation of a strategic partnership with Great Point Partners, LLC.
  • Advised Panaxia on merging its pharmaceutical cannabis activities into a public shell, creating one of the leading medical cannabis companies traded on the TASE.

Shibolet & Co.

Shibolet & Co.'s 'excellent team' frequently advises hi-tech and start-up companies operating in the healthcare and life sciences sector on product development, patent approvals, clinical studies and regulatory approval, among others. It is also well known for advising clients on IP transactions, including licensing, transfer and spin-off deals. Einat Weidberg specialises in cross-border M&A, corporate and debt financing. Ofer Ben-Yehuda frequently advises clients on financing, venture capital investments, joint ventures and various other corporate arrangements.

Practice head(s):

Ofer Ben-Yehuda; Einat Weidberg


‘In-depth knowledge of medical cannabis industry.’

‘Commercial knowledge – especially when it comes to complicated international, multi-jurisdictional and cross-border M&A.’

‘Extremely practical and efficient. Very responsive.’

‘Super professional team; very experienced.’ 

Key clients

CartiHeal (2009) Ltd.

ApiFix Ltd.

RDD Pharma Ltd.

Compugen Ltd.

The Trendlines Group Ltd.

NovoCure (Israel) Ltd.

Elron Electronic Industries Ltd.

Alon Medtech Ventures Ltd.

BeyeOnics Surgical Ltd.

OrthoSpin Ltd.

Work highlights

  • Advising CartiHeal on an equity transaction with a US corporation accompanied by a call option, and a put option.
  • Advised ApiFix Ltd. on its acquisition of Orthopediatrics Corp. for an amount comprised of publicly traded shares and cash.
  • Advised Compugen on its follow-on underwritten public offering on Nasdaq.

Tulchinsky Marciano Cohen Levitski & Co.

Tulchinsky Stern Marciano Cohen Levitski & Co.'s 'sharp and knowledge' team has particular strength advising on commercial agreements and corporate transactions, including licensing agreements, investments, joint ventures and fundraising. In a recent highlight, the team advised Cytora, a regenerative medicine company specialising in the development of novel stem cell therapies, on its licensing application. Uri Barak focuses on cross-border M&A, management buyouts, financing rounds and strategic alliances. Alon Tabak-Aviram frequently assists pharmaceutical and bio-tech companies with commercial arrangements and major transactions.

Practice head(s):

Uri Barak; Alon Tabak-Aviram


‘Very professional, quick and excellent advisors on all aspects of healthcare and life sciences law.’

Key clients

Orbotech Ltd.

Teva Pharmaceutical Industries Ltd.

Jerusalem Venture Partners

NextNine Inc.


The National Institute for Biotechnology in the Negev

Fingenom Ltd.

Rank Ranger

RedHill Biopharma Ltd.

ConTIPI Medical Ltd.

AnyClip Ltd.

C2A Security

ADVA Optical Networking



Work highlights

  • Advised Visionix on a joint venture with a Chinese consortium to set up manufacturing and research facilities hub in China.
  • Advising Sanara in relation to all its legal matters since its formation, including portfolio investments and management, capital raising, fund formation and day-to-day corporate and commercial activities.
  • Advising National Institute for Biotechnology in the Negev on its licensing, joint ventures and collaboration activities in Israel and abroad, currently exploring a collaboration with a company in the US, Japan and other jurisdictions.